The Strategy of "Pulmonary Opening by Titration of Positive End-expiratory Pressure" Means of a Pulmonary Recruitment Maneuver in Patients With Acute Respiratory Distress Syndrome: for Which Patients?
NCT ID: NCT04028336
Last Updated: 2021-03-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
4 participants
INTERVENTIONAL
2019-12-20
2021-01-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Optimization of Arterial Oxygen Transport by Positive End-expiratory Pressure Variation in Acute Respiratory Distress Syndrome
NCT01256333
Open Lung Strategy, Gas Distribution and Right Heart Function in ARDS Patients
NCT03202641
Optimization of PEEP for Alveolar Recruitment in ARDS
NCT01949272
Recruitment Maneuvers in ARDS: Effects on Respiratory Function and Inflammatory Markers.
NCT00263146
Stepwise Positive End Expiratory Pressure Elevation For Lung Recruitment in Acute Respiratory Distress Syndrome (ARDS)
NCT01373905
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TITRATION
All patients hospitalized in intensive care and meeting inclusion criteria and without criteria for non-inclusion will be included in this study. All patients will benefit from Lung ultrasound (LUS) and esophageal pressure measurement (Peso) according to the habits of the service. A "PEP titration pulmonary opening" (PEP-OP) test using a recruitment maneuver was then performed in all patients followed by a new LUS and Peso measurement.
TITRATION
PEP titration pulmonary opening (PEP-OP) was performed in all patients followed by new LUS and Peso measurement.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
TITRATION
PEP titration pulmonary opening (PEP-OP) was performed in all patients followed by new LUS and Peso measurement.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Major patient (age ≥18 years)
* Controlled assisted ventilation, sedation and curarization adapted to the respirator.
* Within the first 72 hours of an ARDS (PaO2 / FiO2 ≤ 200 mmHg, FiO2 ≥ 60% and PEEP of ≥5 cmH20) (as recommended by the Berlin criteria)
* Decision of intensivist in charge of the patient to put an oesophageal probe
* After hemodynamic optimization (evaluation of the preload dependence and need for catecholamines)
* Decision of the intensivist in charge of the patient to perform a pulmonary opening test by titration of PEEP by means of a pulmonary recruitment test.
Exclusion Criteria
* Pregnant women, women who are parturient or breastfeeding
* Patients with pulmonary broncho-emphysematous pathology or at risk of presenting it.
* Patients with a history of barotrauma or at risk of presenting it.
* Patients with a history of intracranial hypertension
* Patients with suspected or proven right ventricular dysfunction or uncontrolled hemodynamic instability after hemodynamic management.
* Patients with a contraindication to the placement of an oesophageal tube (esophageal surgery, severe esophageal pathology)
* Patients under guardianship or curatorship or deprived of liberty.
* Patients who are legally protected
* Patient not covered by French national health insurance
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier de Lens
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Julien MARC, DR
Role: PRINCIPAL_INVESTIGATOR
Hospital of Lens
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chu Amiens
Amiens, , France
CH Arras
Arras, , France
Ch Germon Et Gauthier
Béthune, , France
Hospital Dr Schaffner
Lens, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PI2019-01/OPPRED/DRMARC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.